Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion

Eye

Volumn 22, Issue 1, 2008, Pages 60-64

  Patel, P J ^a   Zaheer, I ^a   Karia, N ^a  

^a Southend University Hospital NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHLORAMPHENICOL; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; BIOMICROSCOPY; CASE STUDY; CATARACT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LONG TERM CARE; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; RECURRENT DISEASE; RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; SIDE EFFECT; SLIT LAMP; SYMPTOMATOLOGY; TONOMETRY; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

EID: 38349169372     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702518     Document Type: Article

References (23)

1. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002; 86: 247-248.
2. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone acetonide for refractory diabetic macular oedema. Ophthalmology 2002; 109: 920-927.
3. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular oedema: An optical coherence tomography study. Ophthalmology 2001; 108: 765-772.
4. Williamson TH, O'Donnell, A. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol 2005; 139: 860-866.
5. Cekic O, Chang S, Tseng JJ, Barile GR, Del Priore LV, Weissman H et al. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 2005; 25: 851-855.
6. Kaushik S, Gupta V, Gupta A, Dogra MR, Singh R. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am J Ophthalmol 2004; 137: 758-760.
7. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP et al. Acute endophthalmitis following intravitreal triamcinolone acetonicle injection. Am J Ophthalmol 2003; 136: 791-796.
8. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003; 121: 1279-1282.
9. The Central Retinal Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997; 115: 486-491.
10. Fekrat S, de Juan Jr E. Chorioretinal venous anastomosis for central retinal vein occlusion: Transvitreal venipuncture. Ophthal Surg Lasers 1999; 30: 52-55.
11. Fekrat S, Goldberg MF, Finkelstein D. Laser-induced chorioretinal venous anastomosis for nonischaemic central or branch retinal vein occlusion [comment]. Arch Ophthalmol 1998; 116: 43-52.
12. Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ. Radial optic neurotomy for central retinal vein occlusion: A retrospective pilot study of 11 consecutive cases. Retina 2001; 21: 408-415.
13. Branch Retinal Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous haemorrhage in branch vein occlusion. A randomised clinical trial. Arch Ophthalmol 1984; 104: 34-41.
14. Branch Retinal Vein Occlusion Study Group. Argon laser scatter photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984; 98: 271-282.
15. Michels RG, Gass JDM. The natural course of retinal branch vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: OP166-OP177.
16. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 136: 419-425.
17. Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA et al Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004; 122: 1131-1136.
18. Nauck M, Karakiulakis G. Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998; 341: 309-315.
19. Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S. Increased levels of vascular endothelial growh factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 2002; 133: 70-77.
20. Aiello LP, Bursell SE, Clermont A. Duh E, Ishii H, Takagi C et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997; 46 1473-1480.
21. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24-27.
22. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 1999; 27: 431-432.
23. Scott IU, Ip MS. It's time for a clinical trial to investigate intravitreal triamcinolone for macular edema due to retinal vein occlusion: The SCORE study. Arch Opthalmol 2005; 123: 581-582.